Literature DB >> 24442720

Successful treatment of AIDS-associated, primary CNS lymphoma with rituximab- and methotrexate-based chemotherapy and autologous stem cell transplantation.

T Wolf1, T Kiderlen, J Atta, C Stephan, G Kann, H-R Brodt, C Brandts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24442720     DOI： 10.1007/s15010-013-0579-8

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  4 in total

1.  Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery.

Authors:  C Hoffmann; S Tabrizian; E Wolf; C Eggers; A Stoehr; A Plettenberg; T Buhk; H J Stellbrink; H A Horst; H Jäger; T Rosenkranz
Journal:  AIDS       Date:  2001-11-09       Impact factor: 4.177

2.  High-dose chemotherapy and autologous stem-cell transplantation without consolidating radiotherapy as first-line treatment for primary lymphoma of the central nervous system.

Authors:  Gerald Illerhaus; Fabian Müller; Friedrich Feuerhake; Arnd-Oliver Schäfer; Christoph Ostertag; Jürgen Finke
Journal:  Haematologica       Date:  2008-01       Impact factor: 9.941

3.  High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.

Authors:  Gerald Illerhaus; Reinhard Marks; Gabriele Ihorst; Roland Guttenberger; Christoph Ostertag; Günther Derigs; Norbert Frickhofen; Friedrich Feuerhake; Benedikt Volk; Jürgen Finke
Journal:  J Clin Oncol       Date:  2006-07-24       Impact factor: 44.544

4.  Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART).

Authors:  Timo Wolf; Hans-Reinhard Brodt; Stephan Fichtlscherer; Kathleen Mantzsch; Dieter Hoelzer; Eilke B Helm; Paris S Mitrou; Kai Uwe Chow
Journal:  Leuk Lymphoma       Date:  2005-02
  4 in total
  4 in total

1.  Outcomes for HIV-positive patients with primary central nervous system lymphoma after high-dose chemotherapy and auto-SCT.

Authors:  A O'Neill; K Mikesch; K Fritsch; B Kasenda; L Banerjee; F Burns; G Zakout; R Johnston; G Illerhaus; K Cwynarski
Journal:  Bone Marrow Transplant       Date:  2015-04-13       Impact factor: 5.483

2.  Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexate.

Authors:  Kathryn Lurain; Thomas S Uldrick; Ramya Ramaswami; Mark N Polizzotto; Priscila H Goncalves; Anaida Widell; Seth M Steinberg; Elaine S Jaffe; Stefania Pittaluga; Hao-Wei Wang; Constance M Yuan; Mary Anne Tamula; Staci Martin; Pamela L Wolters; Jomy George; Richard F Little; Robert Yarchoan
Journal:  Blood       Date:  2020-11-05       Impact factor: 22.113

Review 3.  Primary CNS lymphoma.

Authors:  Elizabeth H Phillips; Christopher P Fox; Kate Cwynarski
Journal:  Curr Hematol Malig Rep       Date:  2014-09       Impact factor: 3.952

Review 4.  Stem cell transplantation in strategies for curing HIV/AIDS.

Authors:  Gero Hütter
Journal:  AIDS Res Ther       Date:  2016-09-13       Impact factor: 2.250
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.